Tweets
"Belt & Suspenders" strategy - both COVID-19 vaccination & PrEP (Evusheld) needed to prevent SARS-CoV-2 in moderately to severely immunocompromised pts (transplant, cancer, immunodeficiency) and active poorly controlled autoimmune Dz https://t.co/RmflniD7rD https://t.co/K7pmQtqcOb
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
TONIGHT! Join us at for Tuesday Night Rheumatology at 7pm ET.
This webinar will share highlights from these lectures followed by live audience Q & A:
Treatment Choices in Refractory RA
Adherence to Rheumatoid Therapies
Precision Medicine in RA
https://t.co/8t6z8Y3JR9 https://t.co/xmIRA7faP5
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Rheumatologic diagnosis through hand exam by Dr. Sarah Chung @ACPinternists #rheumatology #rheumtwitter #MedEd #rheumatoidarthritis #BJHM #Hospitalmedicine #IM2022 #MedTwitter ππ½ https://t.co/qR4zNa4NcX
Brown Journal of Hospital Medicine @BrownJHM ( View Tweet )
4 years 2 months ago
Patient with new onset Colitis while on secukinumab, but is this drug-induced?
https://t.co/tpipGFOHI4 https://t.co/h4QujJdU8O
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Leflunomide responses in #RA assoc w/ high metabolite levels (A77 1726). In 115 LEF Rx Pts, 40% had LDAS/remission. A77 1726 levels neg correlation w/ DAS28-ESR (rβ=ββ 0.42, pβ<β0.001). Levels >10Β΅g/mL & LDAS PPV 70%; NPV 93% https://t.co/V32wUGVWLM https://t.co/L9DwZBwet9
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Hyperuricemia as a biomarker of severe #PsA? Study of 242 PsA pts 30% had hyperuricemia & 6% had gout. Hyperuricemia was significantly associated with age, comorbidity, perph polyarthritis, Jt destruction, less response to treatment. https://t.co/NiPTbknD57 https://t.co/HOC2Bev4R6
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
We completed a whole month of super-charged, focused coverage & education on #PsA.THANKS to the many mavens who contributed! In PSA - "Unless someone like you cares a whole awful lot, nothing is going to get better. Itβs not." -Dr. Seuss, The Lorax https://t.co/Y58klwbS4V https://t.co/f2pnuypwyr
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Study of 33 #RA pts finds nearly half had peripheral neuropathy (48.5%); sensorimotor in 64.7%, motor in 17.6%. Neuropathy was NOT associated with age, gender, disease activity, functionality, or falls https://t.co/r2aQI2cm27 https://t.co/OOQlWkCAft
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Prolonged TNF Inhibitor Use Delays Sacroiliac Progression
https://t.co/dz4d8q8XSy https://t.co/NWCAb0OH7B
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Intraarticular Steroids in Hip Osteoarthritis - Do They Work?
https://t.co/AP9jo96xQo https://t.co/tYvP20Qpqh
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Playback now available! Watch our Tuesday Nite Rheumatology, held April 26th, 2022, which featured a Journal Club panel discussion about two important studies.
https://t.co/RjFRFt6oJQ https://t.co/zOxCDC1atS
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Biologics for JIA? Not So Fast, Say Insurers
It's not a simple matter to prescribe tumor necrosis factor (TNF) inhibitors for patients with juvenile idiopathic arthritis (JIA), at least those with insurance, a single-center study found.
https://t.co/w4A5sgv3fU https://t.co/coVh3zui2z
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago


